Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Philip Coombes

Equity Research Analyst

Philip Coombes portrait

Coverage

TrygSkjern BankDanske BankNorth MediaFøroya BankiD/S NordenSparekassen Sjælland-FynAsetekNTG Nordic Transport GroupBooztSKAKOMT Højgaard HoldingSP GroupHafniaFlügger GroupRoblonAscelia PharmaXplora TechnologiesRTXVestjysk BankNetcompany GroupErriaGrønlandsbankenTormDFDSCurasightBioPortoGubraExpreS2ion Biotech HoldingGabriel Holding

Latest content

ShowingAll content types

Hafnia (Investment Case): Strong cash flow and dividends in the face of geopolitical uncertainty

Research 2026-03-09 16:36 by Philip Coombes
Hafnia

Gubra (One-pager): Enters 2026 with three differentiated obesity candidates — pivotal data readouts expected in 2026

Research 2026-03-09 08:29 by Philip Coombes, Michael Friis
Gubra

TORM (One-pager): Leading product tanker operator with strong cash generation

Research 2026-03-06 12:49 by Philip Coombes, Rasmus Køjborg
Torm

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

North Media (One-pager): FY2025 Cash generation underpins value in a structurally declining market

Research 2026-03-04 12:53 by Philip Coombes, Rasmus Køjborg
North Media

ExpreS2ion Biotech - Intention to carry out rights issue to fully fund Phase 1 trial

Analyst Comment 2026-03-02 17:52 by Philip Coombes
ExpreS2ion Biotech Holding

Gubra FY2025 – Clinical progress the focus in 2026 after record year with AbbVie partnership

Analyst Comment 2026-02-27 12:20 by Philip Coombes
Gubra

NORDEN (One-pager): Asset-flexible shipping generating strong ROIC through cycles

Research 2026-02-26 13:05 by Philip Coombes, Rasmus Køjborg
D/S Norden

ExpreS2ion Biotech (One-pager): Progress continues on both pipeline and partner driven programs

Research 2026-02-25 14:19 by Philip Coombes, Michael Friis
ExpreS2ion Biotech Holding

Danske Bank (One-pager): Strong 2025 and still a compelling redistribution story

Research 2026-02-25 12:13 by Rasmus Køjborg, Philip Coombes
Danske Bank

ISS (One-pager): Compounding capital return with targeted organic growth strategy

Research 2026-02-25 08:46 by Philip Coombes, Rasmus Køjborg
ISS
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.